The team successfully disrupted the virus's ability to infect human liver cells in the laboratory using a compound already in clinical trials against cancer—laying the groundwork for animal model ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising path toward a new therapeutic tool against HBV," says Viviana I. Risca, head ...

Hepatitis B is a global health challenge despite the availability ... Future research out of Burwitz's lab will focus on using the transgenic model to study chronic infections and test therapeutic ...